Predicting fatal sepsis in burn patients.

Predicting and managing sepsis in burn patients: current perspectives.

Raoultella ornithinolytica causing fatal sepsis.

Predicting resource utilization in burn treatment.

Fatal sepsis following peripheral intravenous cannula embolus.

Sepsis in the burn patient: a different problem than sepsis in the general population.

Serum markers of sepsis in burn patients: it takes more to convince!

Evaluation of optimized continuous venovenous hemodiafiltration therapy efficiency in severe burn patients with sepsis.

Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients.

Fatal ureaplasmal pneumonia and sepsis in a newborn infant.

Fatal group G streptococcal sepsis in a neonate.

Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients.

A new marker of sepsis post burn injury?*.

Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.

Fatal sepsis associated with an intrauterine device and pregnancy.

[Fatal sepsis due to an emerging bacteria: Arcanobacterium hemolyticum].

Fatal Yersinia enterocolitica (serotype 0:5,27) sepsis after blood transfusion.

A comprehensive method for predicting fatal liver failure of patients with liver cancer resection.

Tracheostomy in pediatric burn patients.

Aztreonam pharmacokinetics in burn patients.

Inhalation injury in burn patients.

Biomarkers Predicting Survival of Sepsis Patients Treated with Continuous Renal Replacement Therapy.

Splenic autotransplantation provides protection against fatal sepsis in young but not in old rats.

Nutrition and metabolism in burn patients.

Predictive factors of mortality in burn patients.

Suggest Documents

Predicting and managing sepsis in burn patients: current perspectives.

Raoultella ornithinolytica causing fatal sepsis.

Predicting resource utilization in burn treatment.

Fatal sepsis following peripheral intravenous cannula embolus.

Sepsis in the burn patient: a different problem than sepsis in the general population.

Serum markers of sepsis in burn patients: it takes more to convince!

Evaluation of optimized continuous venovenous hemodiafiltration therapy efficiency in severe burn patients with sepsis.

Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients.

Fatal ureaplasmal pneumonia and sepsis in a newborn infant.

Fatal group G streptococcal sepsis in a neonate.

Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients.

A new marker of sepsis post burn injury?*.

Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.

Fatal sepsis associated with an intrauterine device and pregnancy.

[Fatal sepsis due to an emerging bacteria: Arcanobacterium hemolyticum].

Fatal Yersinia enterocolitica (serotype 0:5,27) sepsis after blood transfusion.

A comprehensive method for predicting fatal liver failure of patients with liver cancer resection.

Tracheostomy in pediatric burn patients.

Aztreonam pharmacokinetics in burn patients.

Inhalation injury in burn patients.

Biomarkers Predicting Survival of Sepsis Patients Treated with Continuous Renal Replacement Therapy.

Splenic autotransplantation provides protection against fatal sepsis in young but not in old rats.

Nutrition and metabolism in burn patients.

Predictive factors of mortality in burn patients.

Predicting fatal sepsis in burn patients.

Recommend Documents

Follow Us